HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
Top Cited Papers
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 32 (4) , 413-423
- https://doi.org/10.1124/dmd.32.4.413
Abstract
The glucuronidation kinetics of the prototypic substrates 4-methylumbelliferone (4MU) and 1-naphthol (1NP) by human UDP-glucuronosyltransferases (UGT) 1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B7, 2B15, and 2B17 were investigated. Where activity was demonstrated, inhibitory effects of diclofenac, probenecid, and the solvents acetone, acetonitrile, dimethyl sulfoxide, ethanol, and methanol were characterized. All isoforms except UGT1A4 glucuronidated 4MU, whereas all but UGT 1A4, 2B15, and 2B17 metabolized 1NP. However, kinetic models varied with substrate (for the same isoform) and from isoform to isoform (with the same substrate). Hyperbolic (Michaelis-Menten), substrate inhibition, and sigmoidal kinetics were variably observed for both 4MU and 1NP glucuronidation by the various UGTs. Km or S50 (sigmoidal kinetics) and Vmax values varied 525- (8–4204 μM) and 5535-fold, respectively, for 4MU glucuronidation, and 1360- (1.3–1768 μM) and 560-fold, respectively, for 1NP glucuronidation. The use of a two-site model proved useful for those reactions exhibiting non-Michaelis-Menten glucuronidation kinetics. The organic solvents generally had a relatively minor effect on UGT isoform activity. UGT 1A6, 2B15, and 2B17 were most susceptible to the presence of solvent, although solvent-selective inhibition was occasionally observed with other isoforms. Diclofenac and probenecid inhibited all isoforms, precluding the use of these compounds for the reaction phenotyping of xenobiotic glucuronidation pathways in human tissues. Diclofenac and probenecid Ki values, determined for selected isoforms, ranged from 11 to 60 μM and 96 to 2790 μM, respectively. Overall, the results emphasize the need for the careful design and interpretation of kinetic and inhibition studies with human UGTs.Keywords
This publication has 34 references indexed in Scilit:
- Typical and Atypical Enzyme KineticsPublished by Taylor & Francis ,2003
- EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISMDrug Metabolism and Disposition, 2003
- Quinidine and Haloperidol as Modifiers of CYP3A4 Activity: Multisite Kinetic Model ApproachDrug Metabolism and Disposition, 2002
- In vitro–in vivo correlations for drugs eliminated by glucuronidation: Investigations with the model substrate zidovudineBritish Journal of Clinical Pharmacology, 2002
- Homodimerization of Human Bilirubin-Uridine-diphosphoglucuronate Glucuronosyltransferase-1 (UGT1A1) and Its Functional ImplicationsJournal of Biological Chemistry, 2001
- Development of a Bicistronic Vector Driven by the Human Polypeptide Chain Elongation Factor 1α Promoter for Creation of Stable Mammalian Cell Lines That Express Very High Levels of Recombinant ProteinsBiochemical and Biophysical Research Communications, 1998
- Isolation and Characterization of a Human Orphan UDP-Glucuronosyltransferase, UGT2B11Biochemical and Biophysical Research Communications, 1998
- Protein−Protein Interactions between UDP-Glucuronosyltransferase Isozymes in Rat Hepatic MicrosomesBiochemistry, 1997
- cDNA Cloning and Expression of Two New Members of the Human Liver UDP-Glucuronosyltransferase 2B SubfamilyBiochemical and Biophysical Research Communications, 1993
- UDP-glucuronosyltransferase activitiesBiochemical Pharmacology, 1983